1 / 17

Congenital Thrombophilias : an overview

Congenital Thrombophilias : an overview. Mohannad Ibn Homaid. General principles. We develop thrombosis when we are Deficient in clotting factor inhibitor Producing more coagulation factor either quantitativley or functionally . Group 1 Disorders. Protein C Deficiency. Physiology

ellery
Download Presentation

Congenital Thrombophilias : an overview

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Congenital Thrombophilias:an overview MohannadIbnHomaid

  2. General principles • We develop thrombosis when we are • Deficient in clotting factor inhibitor • Producing more coagulation factor either quantitativley or functionally

  3. Group 1 Disorders

  4. Protein C Deficiency • Physiology • Mutations : 2 Types • Dillema • Presentation • Homozygotes present as neonatal purpurafulminans • Heterozygotes develop thrombosis a bit later or when exposed to warfarin • Diagnosis • Measuring Functional and antigenic levels • PCR

  5. Protein S Deficiency • Practically the same as Protein C deficiency • Physiology. Unbound Levels vs bound Levels • Mutation

  6. Anti Thrombin 3 Deficiency • Physiology • Inactivates factors 2-12-11-10-9 • Relationship with heparin • Mutations • 3 Types • Dillema • Presentation • Severe thrombosis even with functional levels of 70-80% • Homozygosity • Diagnosis

  7. Group 2 Disorders

  8. Activated protein C resistance and Factor V leiden • Physiology • Factor V inactivated by • Mutations • The leiden Allele • Found in 90% with APR • Presentation • Most common • Generally Higher risk than normal population but not severe enough to cause purpurafulminanas • Diagnosis • APR: clotting Assay • Factor V leiden :PCR

  9. Prothrombin 201020 A mutation • Physiology: • Cleaves Fibrinogen to fibrin monomers • Mutations • Gain of Function Mutation • mRNA doesn’t break down so it accumulates produces more prothrombin • Presentation • Same as all group 2 Disorders • Diagnosis • PCR

  10. Dysfibrinogenemia • Physiology • Cleaved by thrombin into fibrin • Aids in stabilizing platelet plugs • DYS-fibrinogenemia ? • Presentation • 50% asymptomatic • 50% Symtomatic • Oslo 1 Mutation 10% • Diagnosis • Functional Assays

  11. Other Disorders

  12. Homocystinuria

More Related